PLA2R1 and dermatofibrosarcoma protuberans: An increased expression of PLA2R1 was also demonstrated in ovarian carcinoma effusions [15], dermatofibrosarcoma [16], and human prostate cancer cell line PC-3 [17, 18], contradicting an exclusive function of PLA2R1 as tumour-suppressor.